Joris A.
- Country
- Belgium
- Department
- Gastroenterology
Research Overview
- Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of Brenipatide (LY3537031) for Efficacy and Safety in Adults with Irritable Bowel Syndrome‑Constipation
- Efficacy and Safety of Tezepelumab in Eosinophilic Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Data & Insights
Has run more than one trial at 26 of 103 partner sites.
Specializations
Gastrointestinal Disorders
This investigator specializes in studying eosinophilic esophagitis (EoE), a chronic inflammatory condition affecting the esophagus. Their research encompasses the evaluation of novel therapeutic approaches for managing this rare disorder.
- Inflammatory esophageal conditions
- Immune-mediated gastrointestinal disorders
- Chronic esophageal dysfunction
Their work includes investigation of tissue inflammation and dysphagia symptoms in EoE patients.
Therapeutic Innovation
The investigator focuses on evaluating emerging treatments including tezepelumab, CC-93538, and solrikitug for gastrointestinal conditions. Their research examines both short-term efficacy and long-term safety profiles.
- Novel therapeutic agents
- Long-term treatment safety
- Histologic response assessment
Their work extends to investigating symptom improvement and treatment tolerability in various patient populations.
Functional Bowel Disorders
The investigator conducts research in Irritable Bowel Syndrome (IBS) treatment modalities, comparing different therapeutic approaches. Their studies evaluate clinical efficacy of various medications including ebastine and mebeverine.
- Comparative treatment efficacy
- Quality of life assessment
- Clinical outcomes evaluation
Their research encompasses quality-adjusted life years and patient well-being measures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.